Glivec 400mg is a targeted therapy used to treat certain types of blood cancers and gastrointestinal tumors. It works by inhibiting specific tyrosine kinases responsible for the growth of cancer cells.
Glivec 400mg, manufactured by Novartis, is a brand of Imatinib Mesylate, a first-generation tyrosine kinase inhibitor (TKI). It has revolutionized the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and other cancers by selectively inhibiting abnormal proteins that promote cancer cell proliferation.
Uses:
Chronic Myeloid Leukemia (CML)
Acute Lymphoblastic Leukemia (ALL) – Philadelphia chromosome-positive
